HHS Cuts Funding To 'Captured' American Academy of Pediatrics
BY JEFF SKINNER
STATEWIDE - Yesterday, the Department of Health and Human Services announced they would be cutting millions in federal grants to the American Academy of Pediatrics, an institution that many have argued is a captured agency by pharmaceutical corporations.
The HHS cancelled seven grants totaling $18.4 million, which the American Academy of Pediatrics argues will significantly impact children. According to the AAP, the grants cancelled were used to target issues pertaining to Sudden Infant Death Syndrome, early autism detection, prevention of fetal alcohol syndrome and adolescent mental health. However, the primary goal of these programs were on educating parents on things like ‘safe sleep’ practices and did not actually strive to investigate the phenomenon of SIDS cases.
According to representatives from HHS, the grants were cancelled due to newly aligned priorities within the agency, which is primarily focused on root cause analysis and tackling things like autism research.
“These grants, previously awarded to the American Academy of Pediatrics, were canceled along with a number of other grants to other organizations because they no longer align with the Department’s mission or priorities,” HHS spokesperson Andrew Nixon said.”
In reality, many studies have proposed strong linkages between vaccines received by children and SIDS cases, with one study indicating that among VAERS data, roughly 79 percent of child death reports occurred post vaccination at a wellness visit. While the research papers available have been careful historically not to classify listed post-vaccination deaths of infants as ‘SIDS’, it has become a growing unavoidable conversation among researchers that over 26 percent of officially recorded SIDS cases occurred directly after a ‘wellness visit’.
The AAP has been adamant that the root cause of these issues is due to sleeping positions. However, the agency has a noted history of pushing claims, such as supporting gender transitions to minors, that lack scientific or evidential backing, calling into question of whether the agency is actually truly investigating research data and reporting signaling for their claims, or simply going along with what might best benefit pharmaceutical companies.
It has been noted that the AAP is also embroiled in litigation against HHS due to recent changes to the vaccine schedule, including removing Hepatitis B vaccine from the newborn recommendations. Something they believe is 'dangerous', though there is no scientific evidence to suggest the removal of the recommendation poses a harm to infants.
Regardless of the rationale, the move from HHS represents a significant departure for the department historically, which has traditionally refused to investigate warning signs in data, and provided funding to agencies like the AAP without question.
